Study investigating advanced MRI scans to detect prostate cancer set to begin

Share this content:

the ONA take:

A new technique that employs advanced MRI scans to diagnose prostate cancer is being tested in a nationwide trial. Tim Dudderidge, a consultant urological surgeon based at Southampton General Hospital, one of the ten centers involved in the trial, has cited the shortcomings of the traditional biopsy procedure; men with a raised PSA are typically advised to have a biopsy, but the biopsy may either miss existing cancer or lead to unnecessary surgery in the case of slow-growing cancer.

Traditional technique uses an ultrasound probe to guide a needle through the rectal walls and into the prostate for sample extraction. The procedure is normally performed on a patient under local anesthetic. The new procedure under review uses cutting-edge image technology, multi parametric (MP) MRI, to create very accurate scans to help determine location, size, and aggressiveness of the prostate cancer.

If successful, the advanced MRI technique could eliminate or reduce the need for invasive biopsies in some men, and provide greater detail at an earlier stage for men with conditions that warrant treatment. The trial involves ten centers spread across the country, with the goal to recruit 700 individuals with prostate cancer by October 2015 for participation. 

For patients with localized prostate cancer, androgen deprivation therapy may be harmful
A new technique that employs advanced MRI scans to diagnose prostate cancer is being tested in a nationwide trial.
A new and more potentially more accurate technique to diagnose prostate cancer without the need for invasive biopsies is being tested in a nationwide trial.
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs